Advertisement

Biobanking for ‘Omics’ in Psychiatry: Logistical and Ethical Aspects

  • Fanny Aldinger
  • Laura Flatau
  • Vishwajit L Nimgaonkar
  • James B. Potash
  • Jana Strohmaier
  • Stephanie H. Witt
  • Marcella Rietschel
  • Thomas G. Schulze
Chapter

Abstract

Biobanks are highly specialized repositories for both biospecimens and associated demographic or clinical data. They have become a crucial component of big data research in all fields of medicine, in particular as regards genomic approaches. However, biobanking faces several non-trivial logistical and ethical questions, with the majority of logistical and conceptual issues arising from the ethical challenges.

Keywords

Genetics Informed consent Broad consent Data protection 

References

  1. 1.
    WHO. The global burden of disease: 2004 update. Geneva: WHO; 2008. term “burden Dis Indic gap between actual ideal Heal status It is Meas Disabil Adjust life years (DALY)”, a Comb years life lost due to premature Mortal time lived less than full Heal [Internet]. 2014 [cited 2016 Nov 8];13. Available from: http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdf?ua=1.
  2. 2.
    Sullivan PF. The psychiatric GWAS consortium: big science comes to psychiatry. Neuron. 2010;68(2):182–6.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Smoller JW, Ripke S, Lee PH, Neale BM, Nurnberger J, Santangelo S, et al. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet. 2013;381(9875):1371–9. http://atgu.mgh.harvard.edu/inrich CrossRefGoogle Scholar
  4. 4.
    Husedzinovic A, Ose D, Schickhardt C, Fröhling S, Winkler EC. Stakeholders’ perspectives on biobank-based genomic research: systematic review of the literature. Eur J Hum Genet. 2015;23(12):1607–14. http://www.ncbi.nlm.nih.gov/pubmed/25735479 CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Gymrek M, McGuire AL, Golan D, Halperin E, Erlich Y. Identifying personal genomes by surname inference. Science. 2013;339(6117):321–4. http://www.ncbi.nlm.nih.gov/pubmed/23329047 CrossRefPubMedGoogle Scholar
  6. 6.
    Ravid R. Standard operating procedures, ethical and legal regulations in BTB (brain/tissue/bio) banking: what is still missing? Cell Tissue Banking. 2008;9(2):121–37.CrossRefPubMedGoogle Scholar
  7. 7.
    Kahn SD. On the future of genomic data. Science. 2011;331(6018):728–9. http://www.ncbi.nlm.nih.gov/pubmed/21311016 CrossRefPubMedGoogle Scholar
  8. 8.
    Molnar MJ, Bencsik P. Establishing a neurological-psychiatric biobank: banking, informatics, ethics. Cell Immunol. 2006;244(2):101–4.CrossRefPubMedGoogle Scholar
  9. 9.
    World Medical Association. WMA declaration of taipei on ethical considerations regarding health databases and biobanks [Internet]. 2016 [cited 2017 Jan 13]. pp. 1–3. Available from: http://www.wma.net/en/30publications/10policies/d1/.
  10. 10.
    Wolf SM, Crock BN, Van Ness B, Lawrenz F, Kahn JP, Beskow LM, et al. Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Genet Med. 2012;14(4):361–84. http://www.ncbi.nlm.nih.gov/pubmed/22436882 CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Green RC, Berg JS, Grody WW, Kalia SS, Korf BR, Martin CL, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013;15(7):565–74. http://www.ncbi.nlm.nih.gov/pubmed/23788249 CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Ormond KE, Cirino AL, Helenowski IB, Chisholm RL, Wolf WA. Assessing the understanding of biobank participants. Am J Med Genet A. 2009;149A(2):188–98. http://www.ncbi.nlm.nih.gov/pubmed/19161150 CrossRefPubMedGoogle Scholar
  13. 13.
    Clayton EW. Informed consent and biobanks. J Law Med Ethics. 2005;33(1):15–21. http://doi.wiley.com/10.1111/j.1748-720X.2005.tb00206.x CrossRefPubMedGoogle Scholar
  14. 14.
    Hoffmann M, Überblick H. Handbuch Ethik und Recht der Forschung am Menschen. New York: Springer; 2014. p. XXVIII–675S.Google Scholar
  15. 15.
    Moore E, Adams H, Ellis T, Thibault P, JL Sullivan M. Assessing catastrophic thinking associated with debilitating mental health conditions. Disabil Rehabil. 2016:1–6. http://www.ncbi.nlm.nih.gov/pubmed/27866430
  16. 16.
    Mehl S, Landsberg MW, Schmidt A-C, Cabanis M, Bechdolf A, Herrlich J, et al. Why do bad things happen to me? attributional style, depressed mood, and persecutory delusions in patients with schizophrenia. Schizophr Bull. 40(6):1338–46. http://www.ncbi.nlm.nih.gov/pubmed/24743864 CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Pommerening K. Das Datenschutzkonzept der TMF für Biomaterialbanken (The TMF data protection scheme for biobanks). Inf Technol. 2007;49(6):352–9. http://www.files/20/itti0706_352a.pdf Google Scholar
  18. 18.
    Reng C-M. Generische Lösungen der TMF zum Datenschutz für die Forschungsnetze in der Medizin. Med. Wiss. Verl.-Ges; 2006.Google Scholar
  19. 19.
    Pommerening K, Sax U, Müller T, Speer R. Integrating eHealth and medical research: the TMF data protection scheme. eHealth Comb Health Telemat Telemed Biomed Eng Bioinf Edge. 2008:5–10.Google Scholar
  20. 20.
    Kalra D, Gertz R, Singleton P, Inskip HM. Confidentiality of personal health information used for research. BMJ. 2006;333(7560):196–8. http://www.bmj.com/content/333/7560/196.full CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Becker R. Ein generisches Datenschutzkonzept für Biomaterialbanken [Internet]. 2006. http://www.tmf-ev.de/Produkte/SOP.aspx.
  22. 22.
    Demiroglu SY, Skrowny D, Quade M, Schwanke J, Budde M, Gullatz V, et al. Managing sensitive phenotypic data and biomaterial in large-scale collaborative psychiatric genetic research projects: practical considerations. Mol Psychiatry. 2012;17(12):1180–5. http://www.ncbi.nlm.nih.gov/pubmed/22392033 CrossRefPubMedGoogle Scholar
  23. 23.
    Nussbeck SY, Skrowny D, O’Donoghue S, Schulze TG, Helbing K. How to design biospecimen identifiers and integrate relevant functionalities into your biospecimen management system. Biopreserv Biobank. 2014;12:199–205.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Schwanke J, Rienhoff O, Schulze TG, Nussbeck SY. Suitability of customer relationship management systems for the management of study participants in biomedical research. Methods Inf Med. 2013;52(4):340–50. http://www.schattauer.de/index.php?id=1214&doi=10.3414/ME12-02-0012 CrossRefPubMedGoogle Scholar
  25. 25.
    German Ethics Council. Human biobanks for research OPINION. 2010.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  • Fanny Aldinger
    • 1
  • Laura Flatau
    • 1
  • Vishwajit L Nimgaonkar
    • 2
  • James B. Potash
    • 3
  • Jana Strohmaier
    • 4
  • Stephanie H. Witt
    • 4
  • Marcella Rietschel
    • 4
    • 5
  • Thomas G. Schulze
    • 1
    • 4
    • 5
  1. 1.Institute of Psychiatric Phenomics and Genomics (IPPG)Medical Center of the University of MunichMunichGermany
  2. 2.Department of PsychiatryUniversity of PittsburghPittsburghUSA
  3. 3.Department of PsychiatryUniversity of IowaIowa CityUSA
  4. 4.Department of Genetic Epidemiology in PsychiatryCentral Institute of Mental Health, Faculty of Medicine Mannheim/University of HeidelbergMannheimGermany
  5. 5.Section on Genetics in PsychiatryWorld Psychiatric Association (WPA)GenevaSwitzerland

Personalised recommendations